Takeda concludes sale of select OTC and non-core assets to Hypera Pharma
This divestment agreement was first announced in March 2020
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
OTC products
Elder Pharma launches ‘Solo’ inhalers
Forays into the Rs 800-crore nasal inhaler segment